omni
aaoms
Share your insight!
At Maxxeus / Community Tissue Services, our commitment to our donors, their families, and tissue recipients, combined with innovative technology, safety, and trusted leadership, have allowed us to be an allograft provider of choice for 25 years.

In 2011, Maxxeus / Community Tissue Services recovered tissues from nearly 4145 donors and returned more than 204,000 grafts to communities around the world. We only accept tissue donors that meet or exceed the donor eligibility requirements set in place by the FDA, AATB, state regulations, and their in-house Medical Directors. Only 5% of donors referred to Community Tissue Services are cleared for final processing.

Strict processing procedures are performed by Maxxeus / Community Tissue Services to ensure our customers have quality, consistent, and safe tissue grafts for transplantation. During processing, a patented cleansing method is used to facilitate the removal of cellular elements from the tissue without affecting osteoinductivity or osteoconductivity and maintaining structural integrity. Grafts are irradiated in their final packaging at the lowest possible dose, determined by packaging and tissue type to ensure a sterility assurance level of 10-6 using ISO 11137 Method 2B. Method 2B is used to determine the lowest dose of gamma irradiation needed to sterilize tissue. Initially, multiple lots of tissue are irradiated with incremental doses. The results of sterility tests from those lots are used in additional tests upon which the final production dose is determined. Community Tissue Services chose this methodology and employed a two media test approach because it is best suited to the variations in bioburden inherent in human tissue. Method 1A is another method being utilized in our industry which is designed to ensure a sterility level in medical devices. Maxxeus / Community Tissue Services feels that Method 2B is more specific to testing human tissue than Method 1A.

Community Tissue Services is the largest nonprofit provider of skin grafts to surgeons for severe burn patients in the United States.

Product Showcase

Maxxeus Corticocancellous 0.25-1.00 mm Allograft

Maxxeus Corticocancellous 0.25-1.00 mm Allograft

Corticocancellous comes from sections of the illium which are ground into several particulate sizes. The blend of cortical and cancellous that results from this process gives this product the structure of cortical, with the open scaffolding for bone to grow into offered by cancellous.

Maxxeus is a brand of Community Tissue Services. Community Tissue Services’ Center for Tissue, Innovation and Research is ISO 13485:2003 certified.

Celebrating 25 years of excellence, Community Tissue Services continues to honor the gift instilled upon us by our donors and their families. Staying committed to our vision, “extraordinary people saving and enhancing lives,” Community Tissue Services fulfills patient transplant needs around the world. In 2011, Maxxeus / Community Tissue Services recovered tissues from nearly 4145 donors and returned more than 204,000 grafts to communities around the world. We only accept tissue donors that meet or exceed the donor eligibility requirements set in place by the FDA, AATB, state regulations, and their in-house Medical Directors. Only 5% of donors referred to Community Tissue Services are cleared for final processing.

Contacts

:


Dental Product Coordinator:

Paul Lehner 937-461-3583
plehner@cbccts.org

<!--BVSEO|dz:18683-en_US|sdk:v1.0.6.0-n|msg:JavaScript-only Display -->
by MultiView ©2014
800-816-6710
aaoms@multiview.com
www.multiview.com